The company will imminently start its third pivotal trial of PF-08634404.
ApexOnco Front Page
Recent articles
But the Day One deal is still 29% below where the shares stood at the start of this year.
After more discontinuations, a new deal brings in fresh blood.
Harmoni-A hits, backing a quiet disclosure about the Harmoni trial.
BG-75202 features among several projects starting first-in-human trials.
Inhibrx reveals three deaths in phase 1, but all predate screening protocols.
There will soon be three PD-(L)1 x VEGF projects in pivotal lung and colorectal cancer trials.
Blackstone follows Abingworth, but why?
